Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus and Sirolimus for GVHD Prophylaxis in Cord Blood Transplant
NCT00133367Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2005
- Primary completion
- Nov 2007
- Modality
- Nanoparticles, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus, nab-sirolimus in graft-versus-host disease (GVHD), sponsored by Massachusetts General Hospital. Started Aug 2005; status: completed.
02
Drugs
tacrolimusnab-sirolimus
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00133367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133367.